NIVF NewGenIvf Group Limited
USHealthcareAs of 2026-07-10 16:00
Why NIVF matters now
NewGenIvf Group Limited (NIVF) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.40 with +6.87% on the session and $265.3K in market capitalization; recent performance reads 1-month -12.02% and YTD -90.85%.
The latest financial table shown here is Q4 2025, with revenue of $1.4M, net income of $-7.7M, and EPS of $-13.04. Investors can compare that operating picture with valuation signals such as P/E 0.07 and FCF yield -1476.1%.
The latest indexable market news headline is "NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is available with a median target of $—; recent insider activity includes Chung Ho Fai filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
0.07
PEG
0.00
P/B
0.02
P/S
0.16
EV/EBITDA
0.48
DCF Value
$-7.34
FCF Yield
-1476.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.7%
Operating Margin
-276.6%
Net Margin
338.2%
ROE
32.7%
ROA
28.0%
ROIC
-24.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.4M | $-7.7M | $-13.04 |
| FY 2025 | $4.7M | $9.9M | $16.80 |
| Q3 2025 | $1.3M | $16.8M | $28.60 |
| Q4 2024 | $1.3M | $-108.0K | $-4.60 |
Analyst Ratings
Consensus
—
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
TH
Exchange
—
Beta
-0.08
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.